BCI Atlas

Cortigent is an American neurostimulation company developing the investigational Orion visual cortical prosthesis, continuing the Second Sight lineage under Vivani ownership.

Company — American

Cortigent

Official site → Valencia, CA, USA

visual cortex · cortical prosthesis · Orion · investigational · neurostimulation

Cortigent is an American neurostimulation company developing Orion, an investigational visual cortical prosthesis system. It continues the former Second Sight technology lineage and operates as a subsidiary of Vivani Medical.

At a glance

  • Focus: visual cortical prosthesis and precision neurostimulation
  • Lead program: Orion (investigational)
  • Corporate lineage: continuation of Second Sight programs/assets
  • Ownership context: subsidiary under Vivani Medical

What they are building (technical)

Orion is designed as a camera + processing + implant stimulation stack targeting visual cortex, aiming to produce interpretable patterned percepts in profoundly blind users.

Public trial-facing materials describe an early feasibility program, with reported long-term follow-up updates presented by the company.

Stage and evidence posture

Cortigent should be treated as a clinical-stage / investigational company in this domain. Public company communications are useful for timeline updates, while ClinicalTrials and peer-reviewed publications are the strongest anchors for interpretation.

What to watch

  • practical daily functional utility (not just percept generation)
  • long-term implant + serviceability stability
  • regulatory pathway clarity for pivotal studies/endpoints

Sources (starting set)